The global newborn screening market is experiencing significant growth, driven by the increasing emphasis on early detection and intervention for neonatal disorders. Newborn screening programs worldwide have expanded, resulting in improved identification and treatment of genetic and metabolic disorders in newborns. These screenings enable timely interventions, reducing morbidity and mortality rates and ensuring healthier futures for newborns. Advancements in technology and government support further boost market growth, empowering healthcare systems to provide comprehensive and effective newborn screening solutions on a global scale.
According to Data Bridge Market Research, the Global Newborn Screening Market is expected to reach the value of USD 0.9 billion in 2021 and is expected to reach USD 1.76 billion by 2029, registering a CAGR of 8.8% during the forecast period of 2022-2029
"Early disease detection surge market demand"
Newborn screening plays a crucial role in early disease detection, allowing healthcare providers to identify genetic and metabolic disorders shortly after birth. Through a simple blood test, potential health issues can be flagged, enabling timely medical intervention and treatment. Early detection allows healthcare professionals to initiate necessary therapies and interventions promptly, preventing the progression of certain disorders and reducing associated complications. This proactive approach empowers families to make informed decisions about their child's health and ensures better outcomes for newborns facing potential health challenges.
What restraints the growth of the global newborn screening market?
" Limited access to newborn screening can impede the market growth”
In low-resource settings, limited access to newborn screening services can be a significant challenge. Factors such as inadequate healthcare infrastructure, lack of trained personnel, and financial constraints may hinder the establishment and maintenance of comprehensive screening programs. As a result, many newborns in these regions may miss out on the benefits of early disease detection and timely interventions.
Segmentation: Global Newborn Screening Market
The global newborn screening market is segmented on the basis of test type, product type, technology, disease type, and end user.
- On the basis of test type, the newborn screening market is segmented into dried blood spot test, hearing screen test, and critical congenital heart diseases (CCHD) test.
- On the basis of product type, the newborn screening market is segmented into instruments, reagents, and assay kits.
- On the basis of technology, the newborn screening market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, and DNA-based assays.
- On the basis of disease type, the newborn screening market is segmented into critical congenital heart diseases, newborn hearing loss, sickle cell disease, phenylketonuria (PKU), cystic fibrosis (CF), maple syrup urine disease, and others.
- On the basis of end user, the newborn screening market is bifurcated into hospital, paediatric clinics, and clinics.
Regional Insights: North America dominates the Global Newborn Screening Market
North America's dominance in the newborn screening market is attributed to several factors. The region hosts major players in the healthcare industry, contributing to advanced technologies and comprehensive screening solutions. Additionally, North America has well-established newborn screening programs, ensuring widespread access to screening services. Moreover, favorable reimbursement policies by governments and healthcare insurers incentivize healthcare providers to offer newborn screening, promoting its adoption. These combined factors create a conducive environment for the growth and leadership of North America in the newborn screening market.
Asia-Pacific's expected significant growth in the newborn screening market is driven by rising awareness about the importance of early diagnosis of genetic and metabolic disorders in newborns. The region has witnessed an increase in the adoption of newborn screening programs, leading to higher screening rates. As healthcare awareness and infrastructure continue to improve, more families are seeking timely interventions for their newborns, contributing to the market's expansion during the forecast period of 2022 to 2029.
To know more about the study, visit, https://www.databridgemarketresearch.com/fr/reports/global-newborn-screening-market
Recent Developments in Global Newborn Screening Market
- In 2020, PerkinElmer, Inc., a worldwide company devoted to developing a healthy society, gained CE-IVD certification for their EONISTM newborn screening assay, which screens for SMA (spinal muscular atrophy), SCID (severe combined immunodeficiency), and XLA (X-linked agammaglobulinemia).
The Prominent Key Players Operating in the Global Newborn Screening Market Include:
- PerkinElmer Inc., (U.S.)
- Demant A/S (Denmark)
- Natus Medical Incorporated (U.S.)
- Bio-Rad Laboratories (U.S.)
- Luminex Corporation (U.S.)
- F. Hoffmann-La Roche Ltd., (Switzerland)
- Thermo Fisher Scientific Inc., (U.S.)
- Bruker (U.S.)
- Danaher (U.S.)
- Medtronic (Ireland)
- Chromsystems Instruments & Chemicals GmbH (Germany)
- Trivitron Healthcare (India)
- Baebies Inc., (U.S.)
- RECIPE Chemicals + Instruments GmbH (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global newborn screening market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Newborn Screening Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
